Gabalex Capital Management’s Medtronic MDT Stock Holding History

Gabalex Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-80,000	Closed	-$7.34M	–	24
2020 Q2	$7.34M	Buy	80,000 +15,000	+23%	+$1.44M	2.31%	20
2020 Q1	$5.86M	Hold	65,000	–	–	2.02%	17
2019 Q4	$7.37M	Hold	65,000	–	–	1.93%	18
2019 Q3	$7.06M	Hold	65,000	–	–	1.9%	19
2019 Q2	$6.33M	Buy	65,000 +15,000	+30%	+$1.37M	1.65%	19
2019 Q1	$4.55M	Buy	+50,000	New	+$4.48M	1.32%	18
2014 Q3	–	Sell	-100,000	Closed	-$6.38M	–	14
2014 Q2	$6.38M	Sell	100,000 -50,000	-33%	-$3.04M	2.4%	12
2014 Q1	$9.23M	Hold	150,000	–	–	3.32%	10
2013 Q4	$8.61M	Hold	150,000	–	–	2.63%	12
2013 Q3	$7.99M	Sell	150,000 -50,000	-25%	-$2.69M	2.66%	11
2013 Q2	$10.3M	Buy	+200,000	New	+$9.89M	3.53%	11

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gabalex Capital Management's MDT Position: Q3 2020 in Review

Gabalex Capital Management sold out of Medtronic (MDT) in Q3 2020, closing a stake of 80,000 shares — an estimated $7.34M sold.

Gabalex Capital Management first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $10.3M in Q2 2013. 1,811 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

Gabalex Capital Management reported no remaining Medtronic position as of Q3 2020 after selling out during the quarter.
Gabalex Capital Management sold 80,000 Medtronic shares in Q3 2020, an estimated $7.34M.
Gabalex Capital Management first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
Gabalex Capital Management's Medtronic position peaked at $10.3M in Q2 2013.
1,811 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on Gabalex Capital Management's 13F filing for Q3 2020, filed 3 Nov 2020.